920978-98-9

Basic information

• Product Name: 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 1-[(3-fluorophenyl)methyl]-5-(trifluoromethyl)-, ethyl ester
• CAS NO: 920978-98-9
• Molecular Formula: C18H14F4N2O2
• Molecular Weight: 366.315
• Mol File: 920978-98-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 1-[(3-fluorophenyl)methyl]-5-(trifluoromethyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 1-[(3-fluorophenyl)methyl]-5-(trifluoromethyl)-, ethyl ester(920978-98-9)
• EPA Substance Registry System: 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 1-[(3-fluorophenyl)methyl]-5-(trifluoromethyl)-, ethyl ester(920978-98-9)

Safety Data

• Hazardous Substances Data: 920978-98-9(Hazardous Substances Data)

Usage

Structure

Ethyl ester derivative of pyrrolopyridine carboxylic acid

Functional groups

Fluorophenylmethyl group, trifluoromethyl group

Potential applications

Pharmaceuticals, agrochemicals, material science

Need for further research

To understand its potential uses and effects

Upstream product

• 920978-97-8 ethyl 5-trifluoro-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 
• 456-47-3 3-fluoro-benzenemethanol 

Downstream Products

• 1034711-08-4 5-trifluoromethyl-1-[(3-fluoro-phenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid 
• 920978-71-8 N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-trifluoromethyl-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxamide 

Relevant articles and documents

N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy

The invention relates to compounds of the general formula (I): Wherein X, Y, Z, Z1, Z2, Z3, Z4 and n are as defined herein. The invention also relates to a method for making the same and to the use thereof in th

N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

The invention concerns compounds of general formula (I), wherein n, the pyrrolopyridine ring, X, Z1, Z2, Z3, Z4, Z5 and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.